Andrea Cipriani

Summary

Affiliation: University of Verona
Country: Italy

Publications

  1. ncbi request reprint What is a run-in phase?
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Epidemiol Psichiatr Soc 19:21-2. 2010
  2. doi request reprint Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis
    Andrea Cipriani
    Department of Public Health and Community Medicine, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Lancet 378:1306-15. 2011
  3. ncbi request reprint What is a forest plot?
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Piazzale L A Scuro, 10 37134 Verona, Italy
    Epidemiol Psichiatr Soc 15:258-9. 2006
  4. doi request reprint Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial
    Andrea Cipriani
    Section of Psychiatry, Department of Public Health and Community Medicine, University of Verona, Italy
    J Clin Psychopharmacol 33:533-7. 2013
  5. pmc Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial
    Andrea Cipriani
    Dipartimento di Sanità Pubblica e Medicina di Comunità, Sezione di Psichiatria e Sezione di Psicologia Clinica, Universita di Verona, Policlinico G, B, Rossi Piazzale L A Scuro, Verona, 10 37134, Italy
    BMC Psychiatry 13:212. 2013
  6. doi request reprint Citalopram versus other anti-depressive agents for depression
    Andrea Cipriani
    Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy
    Cochrane Database Syst Rev 7:CD006534. 2012
  7. doi request reprint What is a multiple treatments meta-analysis?
    A Cipriani
    Department of Public Health and Community Medicine, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Epidemiol Psychiatr Sci 21:151-3. 2012
  8. ncbi request reprint Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice
    Andrea Cipriani
    Department of Medicine and Public Health, University of Verona, Italy
    Can J Psychiatry 52:553-62. 2007
  9. ncbi request reprint What is an individual patient data meta-analysis?
    Andrea Cipriani
    Epidemiol Psichiatr Soc 16:203-4. 2007
  10. ncbi request reprint What is an intention to treat analysis?
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
    Epidemiol Psichiatr Soc 17:26-7. 2008

Detail Information

Publications62

  1. ncbi request reprint What is a run-in phase?
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Epidemiol Psichiatr Soc 19:21-2. 2010
    ..In this paper we analysed the implications of run-in periods for interpreting the results of clinical trials and applying these results in clinical practice. Study reports should indicate in details how run-in periods were carried out...
  2. doi request reprint Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis
    Andrea Cipriani
    Department of Public Health and Community Medicine, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Lancet 378:1306-15. 2011
    ..We did a multiple-treatments meta-analysis, which accounted for both direct and indirect comparisons, to assess the effects of all antimanic drugs...
  3. ncbi request reprint What is a forest plot?
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Piazzale L A Scuro, 10 37134 Verona, Italy
    Epidemiol Psichiatr Soc 15:258-9. 2006
  4. doi request reprint Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial
    Andrea Cipriani
    Section of Psychiatry, Department of Public Health and Community Medicine, University of Verona, Italy
    J Clin Psychopharmacol 33:533-7. 2013
    ..Long-term studies for patients with resistant schizophrenia are necessary to assess the effectiveness of combination strategies on persisting positive symptoms...
  5. pmc Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial
    Andrea Cipriani
    Dipartimento di Sanità Pubblica e Medicina di Comunità, Sezione di Psichiatria e Sezione di Psicologia Clinica, Universita di Verona, Policlinico G, B, Rossi Piazzale L A Scuro, Verona, 10 37134, Italy
    BMC Psychiatry 13:212. 2013
    ....
  6. doi request reprint Citalopram versus other anti-depressive agents for depression
    Andrea Cipriani
    Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy
    Cochrane Database Syst Rev 7:CD006534. 2012
    ..Citalopram, one of the first selective serotonin reuptake inhibitors (SSRI) introduced in the market, is one of these antidepressant drugs that clinicians use for routine depression care...
  7. doi request reprint What is a multiple treatments meta-analysis?
    A Cipriani
    Department of Public Health and Community Medicine, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Epidemiol Psychiatr Sci 21:151-3. 2012
    ....
  8. ncbi request reprint Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice
    Andrea Cipriani
    Department of Medicine and Public Health, University of Verona, Italy
    Can J Psychiatry 52:553-62. 2007
    ....
  9. ncbi request reprint What is an individual patient data meta-analysis?
    Andrea Cipriani
    Epidemiol Psichiatr Soc 16:203-4. 2007
  10. ncbi request reprint What is an intention to treat analysis?
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
    Epidemiol Psichiatr Soc 17:26-7. 2008
  11. ncbi request reprint Allocation concealment and blinding in clinical trials
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
    Epidemiol Psichiatr Soc 17:115-6. 2008
  12. ncbi request reprint Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Policlinico G B Rossi, Piazzale L A Scuro, 10, 37134 Verona, Italy
    J Clin Psychiatry 69:1732-42. 2008
    ..The aim of this study was to carry out a systematic review and meta-analysis to compare sertraline with any other antidepressant in the acute phase treatment of major depression at 8 weeks...
  13. doi request reprint Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Piazzale L A Scuro 10, Verona, Italy
    J Psychopharmacol 24:1729-38. 2010
    ..We conclude that olanzapine may prevent further manic episodes only in patients who have responded to olanzapine in an acute manic or mixed episode and who have not previously had a satisfactory response to lithium or valproate...
  14. ncbi request reprint Superiority, equivalence or non-inferiority?
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
    Epidemiol Psichiatr Soc 18:311-3. 2009
    ..Three kinds of RCTs may be designed: Superiority trials, Equivalence studies, Non-inferiority studies...
  15. ncbi request reprint What is a clinical trial protocol?
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Epidemiol Psichiatr Soc 19:116-7. 2010
    ..Trial protocols must meet a standard that adheres to the principles of Good Clinical Practice, and are used to obtain ethics approval by local Ethics Committees or Institutional Review Boards...
  16. ncbi request reprint What is a Cochrane review?
    A Cipriani
    Department of Public Health and Community Medicine, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
    Epidemiol Psychiatr Sci 20:231-3. 2011
    ..In this issue, we highlight the most important methodological features of Cochrane reviews, also reporting details on the editorial process to publish the review in the Cochrane Library...
  17. ncbi request reprint What is a risk ratio?
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Piazzale L A Scuro, 10, 37134 Verona, Italy
    Epidemiol Psichiatr Soc 16:20-1. 2007
  18. pmc Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia
    Michela Nose
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Trials 10:31. 2009
    ....
  19. doi request reprint Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial
    Corrado Barbui
    World Health Organization Collaborating Centre for Research and Training in Mental Health and Service Organization, Department of Public Health and Community Medicine, Section of Psychiatry and Clinical Psychology, Verona, Italy
    J Clin Psychopharmacol 31:266-73. 2011
    ..However, an advantage in the perception of adverse effects with aripiprazole treatment may be meaningful for patients...
  20. doi request reprint Duloxetine versus other anti-depressive agents for depression
    Andrea Cipriani
    Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy
    Cochrane Database Syst Rev 10:CD006533. 2012
    ....
  21. ncbi request reprint Sertraline versus other antidepressive agents for depression
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Policlinico G B Rossi, Piazzale L A Scuro, 10, Verona, Italy, 37134
    Cochrane Database Syst Rev 4:CD006117. 2010
    ..However, the included studies did not report on all the outcomes that were pre-specified in the protocol of this review. Outcomes of clear relevance to patients and clinicians were not reported in any of the included studies...
  22. doi request reprint Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Italy Department of Psychiatry, University of Oxford, UK
    Lancet 373:746-58. 2009
    ..We therefore did a multiple-treatments meta-analysis, which accounts for both direct and indirect comparisons, to assess the effects of 12 new-generation antidepressants on major depression...
  23. ncbi request reprint Are all antidepressants really the same? The case of fluoxetine: a systematic review
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
    J Clin Psychiatry 67:850-64. 2006
    ..To systematically review the efficacy and tolerability of fluoxetine, the most widely studied of newer antidepressants, in comparison with all other antidepressants in the acute treatment of depression in patients aged more than 18 years...
  24. doi request reprint Antidepressant drug prescription and risk of abnormal bleeding: a case-control study
    Corrado Barbui
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, WHO Collaborating Centre for Research and Training in Mental Health, University of Verona, Italy
    J Clin Psychopharmacol 29:33-8. 2009
    ..74; 95% CI, 1.04-2.93). In a population with a low baseline risk of bleeding, we detected a significant increase in the risk of gastrointestinal bleeding only...
  25. ncbi request reprint Relationship between quality of reports of antidepressant randomized controlled trials and treatment estimates: systematic review, meta-analysis, and meta-regression analysis
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
    J Clin Psychopharmacol 27:352-6. 2007
    ..However, current quality measures are not related with treatment estimates in antidepressant trials and may not be useful weighting tools when meta-analyses of data extracted from antidepressant RCTs are carried out...
  26. ncbi request reprint Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach
    Antonio Veronese
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Piazzale L A Scuro 10, 37134 Verona, Italy
    Epidemiol Psichiatr Soc 17:236-41. 2008
    ..The present study was carried out to develop concepts which help understand this phenomenon in a natural setting, giving emphasis to views of clinicians according to quali - quantitative research methodologies...
  27. doi request reprint Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study
    Michele Tinazzi
    Department of Neurological, Neuropsychological, Morphological and Motor Sciences, University of Verona, Italy
    Schizophr Res 152:344-9. 2014
    ..Functional imaging of the dopamine transporter can be helpful to select this patient sub-group that might benefit from levodopa therapy. ..
  28. doi request reprint Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
    Andrea Cipriani
    Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy
    BMJ 346:f3646. 2013
    ..To assess whether lithium has a specific preventive effect for suicide and self harm in people with unipolar and bipolar mood disorders...
  29. ncbi request reprint Validity of the impact factor of journals as a measure of randomized controlled trial quality
    Corrado Barbui
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Policlinico G B Rossi, 37134 Verona, Italy
    J Clin Psychiatry 67:37-40. 2006
    ..To assess whether the impact factor, a measure of the frequency with which journal articles are cited in the scientific literature, is a proxy measure of the quality of articles reporting the results of randomized controlled trials...
  30. pmc Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials
    Corrado Barbui
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, World Health Organization Collaborating Centre for Research and Training in Mental Health, University of Verona, Verona, Italy
    CMAJ 178:296-305. 2008
    ..We undertook a systematic review of published and unpublished clinical trial data to determine the effectiveness and acceptability of paroxetine...
  31. doi request reprint Randomized trials published in Chinese or Western journals: comparative empirical analysis
    Marianna Purgato
    Section of Psychiatry, Department of Public Health and Community Medicine, University of Verona, Verona, Italy
    J Clin Psychopharmacol 32:354-61. 2012
    ..The increasing inclusion of Chinese studies in systematic reviews reinforces the need to check the quality of randomized trials that are meta-analyzed...
  32. ncbi request reprint Seven criteria for improving effectiveness trials in psychiatry
    Michele Tansella
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Psychol Med 36:711-20. 2006
    ..There are no published criteria for improving the quality of effectiveness of randomized controlled trials (RCTs) in psychiatry...
  33. pmc Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies
    Corrado Barbui
    World Health Organization Collaborating Centre for Research and Training in Mental Health, Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
    CMAJ 180:291-7. 2009
    ..We explored the association between exposure to SSRIs and risk of suicide completion or attempt...
  34. ncbi request reprint Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation
    Antonio Veronese
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Ospedale Policlinico, 37134, Verona, Italy
    Eur J Clin Pharmacol 63:867-73. 2007
    ....
  35. ncbi request reprint Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials
    Michela Nose
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Int Clin Psychopharmacol 21:345-53. 2006
    ..00, -0.11). No difference was observed between pharmacotherapy and placebo in terms of participants leaving the study early. Pharmacotherapy can exert a modest beneficial effect on some core traits of borderline personality disorder...
  36. pmc Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis
    Corrado Barbui
    Department of Public Health and Community Medicine, Section of Psychiatry and Clinical Psychology, University of Verona, Policlinico GB Rossi, 37134 Verona, Italy
    Br J Psychiatry 198:11-6, sup 1. 2011
    ..Depression is a common condition that has been frequently treated with psychotropics...
  37. doi request reprint Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data
    Corrado Barbui
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
    Evid Based Ment Health 11:34-5. 2008
  38. pmc Does the addition of a second antipsychotic drug improve clozapine treatment?
    Corrado Barbui
    Schizophr Bull 35:458-68. 2009
    ..91, 95% CI = 0.75 to 1.11). We conclude that the evidence base supporting a second antipsychotic in addition to clozapine in partially responsive patients with schizophrenia is weak. This weak evidence indicates modest to absent benefit...
  39. doi request reprint Implementation of treatment guidelines for specialist mental health care
    Corrado Barbui
    Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Policlinico GB Rossi, Piazzale L A Scuro, 10, Verona, Italy, 37134
    Cochrane Database Syst Rev 1:CD009780. 2014
    ..It remains unclear, however, whether treatment guidelines have any impact on provider performance and patient outcomes, and how implementation should be conducted to maximise benefit...
  40. ncbi request reprint Assessing risk of bias in randomized controlled trials
    Marianna Purgato
    Department of Public Health and Community Medicine, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Epidemiol Psichiatr Soc 19:296-7. 2010
    ....
  41. ncbi request reprint Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy
    Margherita Andretta
    Servizio Farmaceutico, ULSS 20, Verona, Italy
    Soc Psychiatry Psychiatr Epidemiol 40:72-7. 2005
    ..In 1994 a change in drug reimbursement status was implemented in Italy according to cost-effectiveness criteria. The aim of this study was to examine the impact of these changes on the use of antipsychotic (AP) drugs...
  42. doi request reprint Conceptual and technical challenges in network meta-analysis
    Andrea Cipriani
    Department of Public Health and Community Medicine, University of Verona, Policlinico G B Rossi, Piazzale L A Scuro 10, 37134 Verona, Italy
    Ann Intern Med 159:130-7. 2013
    ....
  43. doi request reprint Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials
    Markus Koesters
    Department of Psychiatry II, Ulm University, Ulm, Germany
    Br J Psychiatry 203:179-87. 2013
    ..Agomelatine is a novel antidepressant drug with narrative, non-systematic reviews making claims of efficacy...
  44. doi request reprint [¹²³I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism
    Michele Tinazzi
    Department of Neurological, Neuropsychological, Morphological and Motor Sciences, University of Verona, Italy
    Schizophr Res 139:40-5. 2012
    ..Longitudinal studies should be designed with the aim of improving our understanding of the mechanisms of pre-synaptic abnormalities in DIP patients and identifying specific treatment strategies...
  45. ncbi request reprint "Wish bias" in antidepressant drug trials?
    Corrado Barbui
    Section of Psychiatry, Department of Medicine and Public Health, University of Verona, Verona, Italy
    J Clin Psychopharmacol 24:126-30. 2004
    ..The evidence that the outcome of fluoxetine trials varied according to whether this drug was used as a new compound or a reference one suggests the presence of bias...
  46. ncbi request reprint Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review
    Sara Mazzucco
    Department of Neurological Sciences and Vision, Section of Clinical Neurology, University of Verona, Piazzale L A Scuro, 10, 37134 Verona, Italy
    Mini Rev Med Chem 8:776-83. 2008
    ..Assessing both randomised and non-randomised evidence, this systematic review found conflicting findings, particularly for risperidone. More research is needed to better inform clinical practice...
  47. doi request reprint Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies
    Corrado Barbui
    Section of Psychiatry, Department of Public Health and Community Medicine, University of Verona, Policlinico GB Rossi, Piazzale Scuro 10, 37134, Verona, Italy
    Drug Saf 37:79-90. 2014
    ..Case reports and observational studies published in the early 1950s suggested that antipsychotic (AP) drugs may represent a risk factor, while observational studies conducted in the last 3 decades have provided conflicting results...
  48. ncbi request reprint Explanatory and pragmatic trials
    Corrado Barbui
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Piazzale L A Scuro, 10 37134 Verona, Italy
    Epidemiol Psichiatr Soc 16:124-5. 2007
  49. ncbi request reprint What is a systematic review?
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Epidemiol Psichiatr Soc 15:174-5. 2006
  50. ncbi request reprint CNS drugs approved by the centralised European procedure: true innovation or dangerous stagnation?
    Corrado Barbui
    Section of Psychiatry and Clinical Psychology, University of Verona, Policlinico GB Rossi, Piazzale Scuro 10, 37134, Verona, Italy
    Psychopharmacology (Berl) 190:265-8. 2007
  51. ncbi request reprint Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials
    Andrea Cipriani
    Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK
    Am J Psychiatry 162:1805-19. 2005
    ....
  52. ncbi request reprint Long-term treatment of depression with antidepressants: a systematic narrative review
    Toshi A Furukawa
    Department of Psychiatry and Cognitive Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Japan
    Can J Psychiatry 52:545-52. 2007
    ..To examine the available scientific evidence for answers to clinically relevant questions on the effectiveness and tolerability of antidepressant drugs (ADs) for the long-term treatment of depression...
  53. ncbi request reprint Publication bias in systematic reviews
    Corrado Barbui
    Arch Gen Psychiatry 64:868. 2007
  54. ncbi request reprint Imputing missing standard deviations in meta-analyses can provide accurate results
    Toshi A Furukawa
    Department of Psychiatry and Cognitive Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Mizuho cho, Mizuho ku, Nagoya 467 8601 Japan
    J Clin Epidemiol 59:7-10. 2006
    ..Some meta-analysts substitute them by those reported in other studies, either from another meta-analysis or from other studies in the same meta-analysis. But the validity of such practices has never been empirically examined...
  55. ncbi request reprint International dosage differences in fluoxetine clinical trials
    Scott Patten
    Department of Community Health Sciences, University of Calgary, Alberta
    Can J Psychiatry 50:31-8. 2005
    ..This study examined international dosage differences in antidepressant clinical trials, using a database formed and maintained as a component of a Cochrane review of comparative clinical trials of fluoxetine...
  56. pmc Selective serotonin reuptake inhibitors
    John R Geddes
    BMJ 329:809-10. 2004
  57. pmc Suicide, depression, and antidepressants
    Andrea Cipriani
    BMJ 330:373-4. 2005
  58. ncbi request reprint Depressive disorder needs an evidence base commensurate with its public health importance
    John R Geddes
    Can J Psychiatry 52:543-4. 2007
  59. pmc Venlafaxine for major depression
    Andrea Cipriani
    BMJ 334:215-6. 2007
  60. ncbi request reprint Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis
    Atsuo Nakagawa
    Department of Neuropsychiatry, Keio University, School of Medicine, Tokyo, Japan
    CNS Drugs 22:587-602. 2008
    ..We undertook a systematic review and meta-analysis of randomized controlled trials that compared the efficacy and tolerability of milnacipran with other antidepressants...
  61. ncbi request reprint Depressive disorders
    Rob Butler
    University of Auckland and Waitemata Health, New Zealand
    Am Fam Physician 73:1999-2004. 2006
  62. ncbi request reprint Imputing response rates from means and standard deviations in meta-analyses
    Toshi A Furukawa
    Department of Psychiatry, Nagoya City University Medical School, Mizuho cho, Mizuho ku, Nagoya, Japan
    Int Clin Psychopharmacol 20:49-52. 2005
    ..This would allow a more robust and clinically interpretable estimation of the true, underlying treatment effect to be made...